iShares MSCI USA Mid-Cap Multifactor ETF
MIDF
MIDF was delisted on the 22nd of August, 2022.
4 hedge funds and large institutions have $1.36M invested in iShares MSCI USA Mid-Cap Multifactor ETF in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, reducing their positions, and 1 closing their positions.
10% less capital invested
Capital invested by funds: $1.51M → $1.36M (-$151K)
20% less funds holding
Funds holding: 5 → 4 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$39.8K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$37.9K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$3.83K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$226K |
MIDF Hedge Fund Activity: Q3 2021 in Review
4 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in iShares MSCI USA Mid-Cap Multifactor ETF (MIDF) for Q3 2021, worth a combined $1.36M — down 10% from $1.51M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of MIDF and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 3 added.
The largest buyer was UBS Group, adding an estimated $39.8K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $226K sold.
- 4 institutional investors held iShares MSCI USA Mid-Cap Multifactor ETF (MIDF) as of Q3 2021, down from 5 in Q2 2021.
- Funds reported $1.36M of iShares MSCI USA Mid-Cap Multifactor ETF stock for Q3 2021, down 10% quarter-over-quarter.
- 0 funds opened new iShares MSCI USA Mid-Cap Multifactor ETF positions in Q3 2021 and 1 closed out, a net change of -1 holder.
- The largest iShares MSCI USA Mid-Cap Multifactor ETF buyer in Q3 2021 was UBS Group, an estimated $39.8K added.
- The largest iShares MSCI USA Mid-Cap Multifactor ETF seller in Q3 2021 was Tower Research Capital (TRC), an estimated $226K sold.
Based on aggregated 13F filings for Q3 2021.